TCT-393 A randomized trial comparing two vascular closure devices: PROGLIDE and the novel EXOSEAL after percutaneous femoral procedures

Obtaining safe and effective closure of the femoral access site following percutaneous coronary interventions (PCI) can sometimes be challenging, especially in patients on anti-coagulation or anti-platelet therapy. Vascular closure devices (VSC) have been shown to shorten hemostasis time, reduce the